...
首页> 外文期刊>Molecular cell >Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein
【24h】

Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein

机译:Hsp90结合TPR蛋白WISp39对p21(WAF1 / CIP1)稳定性的调节

获取原文
获取原文并翻译 | 示例
           

摘要

p21(WAH/CIP1), a cyclin-dependent kinase inhibitor and a critical regulator of cell cycle, is controlled transcriptionally by p53-dependent and -independent mechanisms and posttranslationally by the proteasome. We have identified WISp39, a tetratricopeptide repeat (TPR) protein that binds p21. WISp39 stabilizes newly synthesized p21 protein by preventing its proteasomal degradation. WISp39, p21, and hsp90 form a trimeric complex in vivo. The interaction of WISp39 with Hsp90 is abolished by point mutations within the C-terminal TPR domain of WISp39. Although this WISp39 TPR mutant binds p21 in vivo, it fails to stabilize p21. Our results suggest that WISp39 recruits Hsp90 to regulate p21 protein stability. WISp39 downregulation by siRNA prevents the accumulation of p21 and cell cycle arrest after ionizing radiation. The results demonstrate the importance of posttranslational stabilization of p21 protein by WISp39 in regulating cellular p21 activity.
机译:p21(WAH / CIP1)是一种依赖细胞周期蛋白的激酶抑制剂,是细胞周期的关键调节因子,通过p53依赖性和非依赖性机制进行转录控制,并通过蛋白酶体进行翻译后控制。我们已经确定了WISp39,一种结合p21的四肽重复(TPR)蛋白。 WISp39通过防止其蛋白酶体降解来稳定新合成的p21蛋白。 WISp39,p21和hsp90在体内形成三聚体复合物。 WISp39与Hsp90的相互作用被WISp39的C端TPR域内的点突变所消除。尽管此WISp39 TPR突变体在体内结合p21,但无法稳定p21。我们的结果表明,WISp39募集Hsp90来调节p21蛋白的稳定性。 siRNA WISp39下调可防止p21的积累和电离辐射后细胞周期停滞。结果证明了WISp39对p21蛋白进行翻译后稳定在调节细胞p21活性中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号